Global

Biomedical Sciences Experts

Dr. Markus Rudin

Professor
Dept of Inform Technol Electrical Eng
Institute for Biomedical Engineering
Switzerland

Biography

Markus Rudin is full professor for Molecular Imaging and Functional Pharmacology at the Institute for Biomedical Engineering (D-ITET) since June 2006. Since March 2005 he is also full professor for Molecular Imaging and Functional Pharmacology at the University of Zürich both at the Institute for Biomedical Engineering and the Institute for Pharmacology and Toxicology. Markus Rudin (born 1953, from Lauwil BL) received his diploma in chemistry at the ETHZ in 1976 and his PhD at the Laboratory for Physical Chemistry in 1981 in the field of electron spin resonance / electron-nuclear double resonance, followed by a post-doctorate in the same area. In 1983 he moved to biomedical imaging, joining Sandoz AG to build up a biomedical imaging group initially focused on magnetic resonance imaging. He received his basic training in imaging at the Biocenter of the University of Basel. Within Sandoz AG, later Novartis Pharma AG, he became head of the Biophysics Group, head of the In-vivo Models Unit and finally head of the Analytical and Imaging Science Unit within Discovery Technologies at the Novartis Institutes for Biomedical Research. In this function he was also deputy head of Discovery Technologies until 2005. In 1997 he became Privat Dozent for Biophysics at the University of Basel. Since March 2005, he is member of the Research Council of the Swiss National Science Foundation.

Research Interest

Markus Rudin is heading a research group at the animal imaging center of UZH and ETH located at ETH Hönggerberg focusing on MRI and optical imaging methods (fluorescence tomography). His research focus is the development of non-invasive imaging techniques for studying structure, physiology, and metabolism of tissue as well as cellular and molecular events in the intact organism, in particular assays for monitoring signal transduction pathways. Biomedical applications are in neuroscience and metabolic diseases.

Publications

  • Mueggler, Thomas, and Markus Rudin. "Molecular Imaging of the CNS: Drug Actions." Imaging in CNS Drug Discovery and Development. Springer New York, 2010. 191-211.

  • Klohs, Jan, and Markus Rudin. "Unveiling molecular events in the brain by noninvasive imaging." The Neuroscientist 17.5 (2011): 539-559.

  • Rudin, Markus. "Noninvasive imaging of receptor function: signal transduction pathways and physiological readouts." Current opinion in drug discovery & development 11.5 (2008): 606-615.

Global Experts from Switzerland

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America